abstract |
Provided herein are target HLA-peptide antigens, such as HLA-peptide neoantigens and consensus tumor HLA-peptide antigens, and antigen binding proteins (ABPs) that bind the target HLA-peptide antigens. Also disclosed are methods for identifying target HLA-peptide antigens and identifying one or more antigen binding proteins that bind to a given HLA-peptide target antigen. |